Trastuzumab emtansine

Who we are

  • April 5, 2022
    The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
  • April 5, 2022
    Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
  • April 5, 2022
    Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)